$34.48
0.451.32%
Pre-Market: 4:06 AM EDT
Legend Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Legend Biotech using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-11 | $-0.15 | $-0.33 | 54.5 % |
Q3 | 2024-11-12 | $-0.34 | $-0.42 | 19.1 % |
Q2 | 2024-08-09 | $-0.05 | $-0.38 | 86.8 % |
Q1 | 2024-05-13 | $-0.16 | $-0.34 | 52.9 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-11 | $186.52M | $178.93M | 4.24 % |
Q3 | 2024-11-12 | $160.21M | $143.87M | 11.3 % |
Q2 | 2024-08-09 | $186.52M | $126.59M | 47.3 % |
Q1 | 2024-05-13 | $93.99M | $152.63M | -38.4 % |
Legend Biotech (LEGN) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
The Actual EPS was $-0.15, which beat the estimate of $-0.33.
The Actual Revenue was $186.5M, which beat the estimate of $178.9M.
Browse earnings estimates, EPS, and revenue on all stocks.